Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk

Fasting triacylglycerols have long been associated with cardiovascular disease (CVD) and other cardiometabolic conditions. Evidence suggests that non-fasting triglycerides (i.e. measured within 8 h of eating) better predict CVD than fasting triglycerides, which has led several organisations to recom...

Full description

Bibliographic Details
Main Authors: Bryant H. Keirns, Christina M. Sciarrillo, Nicholas A. Koemel, Sam R. Emerson
Format: Article
Language:English
Published: Cambridge University Press 2021-01-01
Series:Journal of Nutritional Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2048679021000732/type/journal_article
_version_ 1811155921207820288
author Bryant H. Keirns
Christina M. Sciarrillo
Nicholas A. Koemel
Sam R. Emerson
author_facet Bryant H. Keirns
Christina M. Sciarrillo
Nicholas A. Koemel
Sam R. Emerson
author_sort Bryant H. Keirns
collection DOAJ
description Fasting triacylglycerols have long been associated with cardiovascular disease (CVD) and other cardiometabolic conditions. Evidence suggests that non-fasting triglycerides (i.e. measured within 8 h of eating) better predict CVD than fasting triglycerides, which has led several organisations to recommend non-fasting lipid panels as the new clinical standard. However, unstandardised assessment protocols associated with non-fasting triglyceride measurement may lead to misclassification, with at-risk individuals being overlooked. A third type of triglyceride assessment, postprandial testing, is more controlled, yet historically has been difficult to implement due to the time and effort required to execute it. Here, we review differences in assessment, the underlying physiology and the pathophysiological relevance of elevated fasting, non-fasting and postprandial triglycerides. We also present data suggesting that there may be a distinct advantage of postprandial triglycerides, even over non-fasting triglycerides, for early detection of CVD risk and offer suggestions to make postprandial protocols more clinically feasible.
first_indexed 2024-04-10T04:42:56Z
format Article
id doaj.art-75c3ee6dd0844608b2db91d0a960ac22
institution Directory Open Access Journal
issn 2048-6790
language English
last_indexed 2024-04-10T04:42:56Z
publishDate 2021-01-01
publisher Cambridge University Press
record_format Article
series Journal of Nutritional Science
spelling doaj.art-75c3ee6dd0844608b2db91d0a960ac222023-03-09T12:38:46ZengCambridge University PressJournal of Nutritional Science2048-67902021-01-011010.1017/jns.2021.73Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic riskBryant H. Keirns0Christina M. Sciarrillo1Nicholas A. Koemel2Sam R. Emerson3Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74075, USADepartment of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74075, USABoden Collaboration for Obesity, Nutrition, Exercise and Eating Disorders, The University of Sydney, Sydney, NSW 2006, Australia Sydney Medical School, The University of Sydney, Sydney, NSW 2006, AustraliaDepartment of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74075, USAFasting triacylglycerols have long been associated with cardiovascular disease (CVD) and other cardiometabolic conditions. Evidence suggests that non-fasting triglycerides (i.e. measured within 8 h of eating) better predict CVD than fasting triglycerides, which has led several organisations to recommend non-fasting lipid panels as the new clinical standard. However, unstandardised assessment protocols associated with non-fasting triglyceride measurement may lead to misclassification, with at-risk individuals being overlooked. A third type of triglyceride assessment, postprandial testing, is more controlled, yet historically has been difficult to implement due to the time and effort required to execute it. Here, we review differences in assessment, the underlying physiology and the pathophysiological relevance of elevated fasting, non-fasting and postprandial triglycerides. We also present data suggesting that there may be a distinct advantage of postprandial triglycerides, even over non-fasting triglycerides, for early detection of CVD risk and offer suggestions to make postprandial protocols more clinically feasible.https://www.cambridge.org/core/product/identifier/S2048679021000732/type/journal_articleCardiometabolicCardiovascular diseaseFasting triglyceridesNon-fasting triglyceridesPostprandial triglyceridesRisk screeningTriglyceride-rich lipoproteins
spellingShingle Bryant H. Keirns
Christina M. Sciarrillo
Nicholas A. Koemel
Sam R. Emerson
Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
Journal of Nutritional Science
Cardiometabolic
Cardiovascular disease
Fasting triglycerides
Non-fasting triglycerides
Postprandial triglycerides
Risk screening
Triglyceride-rich lipoproteins
title Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
title_full Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
title_fullStr Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
title_full_unstemmed Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
title_short Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
title_sort fasting non fasting and postprandial triglycerides for screening cardiometabolic risk
topic Cardiometabolic
Cardiovascular disease
Fasting triglycerides
Non-fasting triglycerides
Postprandial triglycerides
Risk screening
Triglyceride-rich lipoproteins
url https://www.cambridge.org/core/product/identifier/S2048679021000732/type/journal_article
work_keys_str_mv AT bryanthkeirns fastingnonfastingandpostprandialtriglyceridesforscreeningcardiometabolicrisk
AT christinamsciarrillo fastingnonfastingandpostprandialtriglyceridesforscreeningcardiometabolicrisk
AT nicholasakoemel fastingnonfastingandpostprandialtriglyceridesforscreeningcardiometabolicrisk
AT samremerson fastingnonfastingandpostprandialtriglyceridesforscreeningcardiometabolicrisk